PECAM1 and cancer: A study by Li et al. described a flubendazole treatment model of mice afflicted with melanoma and found that it depressed PD1 expression on melanoma cells themselves and also diminished PECAM-1 expression, thus potentially inhibiting angiogenesis amongst cancer cells (50).